PayerTalkCE

Chapter 2 of a 2-Part CE Podcast

This activity is certified for CME/CNE/CPE credit. To participate and earn

credit, visit us at https://www.impactedu.net/multiple-myeloma-decision-tool/.

As MM progresses to relapsed/refractory MM (RRMM), the selection of an appropriate treatment regimen becomes more complex, requiring an assessment of severity, risk, and prior lines of therapy. Newer agents such as chimeric antigen receptor (CAR) T-cell therapies or bispecific antibody therapies may be indicated. Current treatment guidelines reflect these considerations. However, incorporating appropriate sequences into treatment algorithms and formulary positioning remains challenging for managed care professionals, and emerging agents from the pipeline further complicate assessment. Beyond pharmacotherapy, understanding the total cost of care for various MM treatment options challenges health plan administrators. This activity will help managed care professionals to understand the factors affecting the cost-effectiveness of MM treatments and the total cost of care to ensure the best patient outcomes while managing health care costs.

Chapter 1 of a 2-Part CE Podcast

This activity is certified for CME/CNE/CPE credit. To participate and earn

credit, visit us at https://www.impactedu.net/multiple-myeloma-decision-tool/.

As MM progresses to relapsed/refractory MM (RRMM), the selection of an appropriate treatment regimen becomes more complex, requiring an assessment of severity, risk, and prior lines of therapy. Newer agents such as chimeric antigen receptor (CAR) T-cell therapies or bispecific antibody therapies may be indicated. Current treatment guidelines reflect these considerations. However, incorporating appropriate sequences into treatment algorithms and formulary positioning remains challenging for managed care professionals, and emerging agents from the pipeline further complicate assessment. Beyond pharmacotherapy, understanding the total cost of care for various MM treatment options challenges health plan administrators. This activity will help managed care professionals to understand the factors affecting the cost-effectiveness of MM treatments and the total cost of care to ensure the best patient outcomes while managing health care costs.

This activity is certified for CME/CNE/CPE credit. To participate and earn

credit, visit us at https://www.impactedu.net/sclc-evolving-treatment-landscape.

This activity will provide managed care professionals with a practical, evidence-based review of the evolving treatment landscape in extensive-stage small cell lung cancer (ES-SCLC), with a focus on how emerging clinical data can inform coverage policies, oncology pathways, and utilization management strategies. Participants will explore the mechanisms of action, clinical evidence, and NCCN-recommended use of current first-line, maintenance, and subsequent therapy options; evaluate the impact of treatment sequencing and maintenance optimization on patient outcomes; and examine key considerations related to safety monitoring, response assessment, reauthorization criteria, and site-of-care decisions. Through real-world patient cases, listeners will gain insights into balancing clinical value, operational feasibility, and timely patient access in a rapidly changing ES-SCLC treatment environment.

This activity is certified for CME/CNE/CPE credit. To participate and earn

credit, visit us at https://www.managedcareeye.com/clearer-pathways.

Given emerging evidence and recently updated clinical guidelines in the management of retinal diseases, managed care and payer professionals require competence to integrate emerging clinical trends and updates into the management of retinal diseases. There is a growing need for health care professionals to understand evidence-based care management strategies for retinal diseases to build competence in applying best-practice payer strategies to facilitate high-quality outcomes in retinal diseases.

This activity is certified for CME/CNE/CPE credit. To participate and earn

credit, visit us at https://www.impactedu.net/psoriasis-best-practices/.

The psoriasis treatment landscape is rapidly evolving. Although treatment guidelines are routinely updated, ongoing innovation and the introduction of new therapies frequently render even the most current guidelines incomplete. During this podcast, managed care decision makers will expand their knowledge and learn about the importance of early intervention, prevention, and treatment of associated comorbidities, promotion of healthy lifestyle changes, and implementation of personalized treatment plans.

This activity is certified for CME/CNE/CPE credit. To participate and earn

credit, visit us at https://www.impactedu.net/mg-management.

Managed care professionals face unique challenges in optimizing outcomes for patients with MG, a rare, chronic autoimmune neuromuscular disorder characterized by fluctuating muscle weakness and fatigue. The increasing prevalence and complexity of MG, combined with rapid advances in targeted therapies, require updated knowledge and strategic approaches to coverage, management, and equitable access.

This activity is certified for CME/CNE/CPE credit. To participate and earn

credit, visit us at https://managedcareeye.com/preventing-blindness.

This podcast will highlight challenges across the patient journey—including access to care, benefit design, and coverage decision-making—and their impact on timely diagnosis and treatment. The expert faculty will share payer perspectives on current coverage policies, care coordination, and system-level opportunities to support earlier intervention and evidence-based care. The program will also spotlight best practice strategies successfully implemented by payers to streamline policies, reduce barriers to care, and improve patient outcomes, offering actionable insights for managed care leaders seeking to optimize eye health management and prevent avoidable blindness.

This activity is certified for CME/CNE/CPE credit. To participate and earn

credit, visit us at https://www.managedcareeye.com/bridging-the-gaps/.

This podcast will examine how payer policies shape the real world management of diabetic retinopathy (DR), diabetic macular edema (DME), and age related macular degeneration (AMD), highlighting health care provider insights on the systemic challenges that affect patient access, treatment consistency, and outcomes. Discussion will center on coverage related barriers across the patient journey, including prior authorization requirements, reimbursement constraints, and care coordination gaps that can delay or disrupt sight saving therapies. The expert faculty will outline where current prevention and treatment strategies fall short from the provider perspective and illustrate opportunities for payers to better align policies with clinical needs—ultimately strengthening care delivery, improving decision making at the point of service, and advancing system level approaches to prevent avoidable vision loss.

This activity is certified for CME/CNE/CPE credit. To participate and earn

credit, visit us at https://www.managedcareeye.com/aligning-policy-with-practice/.

Within the space of just a few years, several new retinal treatments have been approved promising increased durability and better patient outcomes. These conditions can significantly impact vision and quality of life for patients. This webcast will explore how clinical realities intersect with coverage policies in the management of diabetic retinopathy (DR), diabetic macular edema (DME), and age related macular degeneration (AMD). This session will highlight current practice patterns, gaps in care, and the unmet needs providers face when navigating treatment decisions for patients at risk of vision loss. Our experts will share candid perspectives on where payer policies support—or hinder—optimal outcomes, and outline practical, evidence aligned strategies payers can adopt to better enable timely, effective care. Attendees will gain a clearer understanding of the shared challenges across stakeholders and learn how collaborative best practices can improve patient outcomes in both DR/DME and AMD.

This activity is certified for CME/CNE/CPE credit. To participate and earn

credit, visit us at https://www.impactedu.net/asthma-management-best-practices/.

Asthma remains a major public health issue in the US, with many patients still uncontrolled despite available treatments and evidence-based guidelines. This leads to preventable ER visits, hospitalizations, and significant costs—over $80 billion annually. The NCQA has updated HEDIS® for 2026 to include a new measure, Follow-Up After Acute and Urgent Care Visits for Asthma (AAF-E), which tracks if patients ages 5–64 receive an outpatient follow-up within 30 days after an asthma-related urgent or emergency visit. This educational activity is designed to increase awareness of the new HEDIS measure to improve outcomes of patients being treated for asthma for both managed care professionals and primary care providers.